2018
DOI: 10.29399/npa.22860
|View full text |Cite
|
Sign up to set email alerts
|

Olanzapine Associated Acute Peripheral Edema and Pericardial Effusion: A Case Report

Abstract: Olanzapine is a potent atypical antipsychotic drug used for the treatment of schizophrenia and bipolar disorder with approved efficiency. Olanzapine is superior to the typical antipsychotic drugs with low incidence of extrapyramidal side effects, especially tardive dyskinesia. The most common side effects associated with olanzapine are constipation, dyspepsia, weight gain, somnolence, asthenia, dry mouth and dizziness. Peripheral edema associated with olanzapine is rarely reported and as far as we know there i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…11,12,14,[20][21][22][23][24][25][26][27][28][29][30] In most cases, symptom resolution occurred after withdrawal, or dose reduction, of olanzapine. 11,12,14,[20][21][22][23][24][25][26][27][28][29][30] Based on these findings, it may be reasonable to rechallenge patients with a lower dose of olanzapine that was previously tolerated. It may also be reasonable to trial augmentation of antidepressants with an alternate SGA if olanzapine at any dose was not tolerated.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…11,12,14,[20][21][22][23][24][25][26][27][28][29][30] In most cases, symptom resolution occurred after withdrawal, or dose reduction, of olanzapine. 11,12,14,[20][21][22][23][24][25][26][27][28][29][30] Based on these findings, it may be reasonable to rechallenge patients with a lower dose of olanzapine that was previously tolerated. It may also be reasonable to trial augmentation of antidepressants with an alternate SGA if olanzapine at any dose was not tolerated.…”
Section: Discussionmentioning
confidence: 99%
“…The degree of variability among case presentation and symptomatic management suggests that additional research on olanzapine-associated edema is warranted to determine when intervention beyond discontinuation of the drug alone is warranted. 11,12,14,[20][21][22][23][24][25][26][27][28][29][30]…”
Section: Discussionmentioning
confidence: 99%
“…63 Agents with a chemical structure similar to that of clozapine include quetiapine and olanzapine, with both implicated in the development of pericarditis, or even constrictive pericarditis in the case of quetiapine. 64,65 The effusion is presumably due to the immune response to the agents administered; the patients often present with eosinophilia and elevated levels of infl ammatory markers; the condition resolves upon therapy discontinuation.…”
Section: Neuroleptic (Antipsychotic) Agentsmentioning
confidence: 99%
“…1 Its most common adverse reactions are weight gain and sedation, 2 although edematous reactions can also occur, usually peripherally. 3 Occasionally, it may appear in other areas, such as the facial region, 4 but this is an uncommon side effect of unknown mechanism for which there are few documented cases in the literature. We present a clinical case of a middle-aged woman who developed facial edema secondary to olanzapine with dose-dependent features.…”
Section: Case Report and Review Of Casesmentioning
confidence: 99%
“…Olanzapine is an atypical antipsychotic used in some pathologies, such as schizophrenia, bipolar disorder, or schizoaffective disorder 1 . Its most common adverse reactions are weight gain and sedation, 2 although edematous reactions can also occur, usually peripherally 3 . Occasionally, it may appear in other areas, such as the facial region, 4 but this is an uncommon side effect of unknown mechanism for which there are few documented cases in the literature.…”
mentioning
confidence: 99%